Figure 1 | Scientific Reports

Figure 1

From: Peptide VSAK maintains tissue glucose uptake and attenuates pro-inflammatory responses caused by LPS in an experimental model of the systemic inflammatory response syndrome: a PET study

Figure 1

Systemic [18F]FDG uptake after the administration of LPS (300 ng/kg) and/or peptide VSAK (60 µg/kg). (A) Schematic representation showing the administration of treatments and PET acquisition procedures. (B) PET images showing the global [18F]FDG uptake of representative experimental rabbits during a 70 min acquisition time. Quantitative analysis for the small intestine (C) and the liver (D) during the different time intervals of PET acquisition (mean of normalized SUV ± SEM). Statistical differences were found in the liver between the LPS and LPS + VSAK groups at 55 min (p = 0.027 *) and 70 min (p = 0.002 **). Control, VSAK; LPS and VSAK + LPS groups, n = 3 for each group. Differences assessed using two-way ANOVA with Tukey’s multiple comparison tests.

Back to article page